Does My Patient Have Early Alzheimer’s Disease? Recognizing and Managing Cognitive Decline in Primary Care
March 31, 2023
March 31, 2024
This activity is jointly provided by Medical Education Resources and Enquiring Minds, LLC.
This activity is supported by an independent education grant from Genentech.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
This activity is designed to meet the educational needs of physicians and other healthcare professionals involved in the care of Alzheimer’s disease.
Challenge yourself as you diagnose patients, tailor treatment plans, and assess expert guidance for 3 patients exhibiting symptoms of cognitive decline.
- Objective and subjective tools for assessing cognitive decline
- Alzheimer’s disease risk factors and presentations
- Diagnostic and therapeutic best practices and guidance
- Patient- and family-centered communication strategies
Upon completion of this activity, participants should be better able to:
- Review key characteristics of cognitive decline and recommend appropriate next steps for determining an early and accurate diagnosis
- Evaluate and integrate the latest clinical evidence and guidance surrounding newly approved and investigational treatments for AD
- Assess and employ patient-centered strategies when tailoring disease management decisions for patients demonstrating symptoms of AD
Marwan Sabbagh, MD, FAAN, CCRI
Professor of Neurology, Alzheimer's and Memory Disorders Division, Barrow Neurological Institute
Research Professor, University of Arizona College of Medicine, Tucson, AZ
Clinical Professor of Neurology, Creighton University
Ida Crocke -Sabbagh, MD, FAAP
Family Medicine Physician
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Enquiring Minds, LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation
Medical Education Resources designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible companies whose products or services may be mentioned in this activity:
- Marwan Sabbagh, MD, FAAN
- Ownership interest (Stock or stock options): Athira, Cognoptix, Cortexyme, NeuroReserve, NeuroTau, Optimal Cognitive Health Company, Seq BioMarque, TransDermix, uMethod Health, Versanum
- Consultant: Alzheon, Biogen, Eisai, KeifeRx, Lilly, NeuroTherapia, Novo Nordisk, Roche-Genentech, Signant Health, Synaptogenix, T3D
- Royalties: HarperCollins, Humanix
Ida Crocke -Sabbagh, MD, FAAP, has no financial relationships to disclose.
The planners at Medical Education Resources and Enquiring Minds, LLC have no relevant financial relationships to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this enduring activity. During the period March 31, 2023 through March 31, 2024, participants must:
- Read the learning objectives and faculty disclosures.
- Participate in the online activity.
- Complete the evaluation form.
A statement of credit will be issued only upon receipt of a completed activity evaluation form. Certificates will be emailed to the participant.
Course Viewing Requirements
Windows: Microsoft Edge (latest version), Google Chrome (latest version), Firefox (latest version)
Mac: Safari (latest version), Google Chrome (latest version), Firefox (latest version)
Mobile: Safari in Apple iOS/iPadOS (latest version), Google Chrome (latest version) in Apple iOS/iPadOS (latest version), Google Chrome (latest version) in Android OS 6 or later
Required Browser Settings
Font Downloads: Must be enabled
No Compatibility View when using Internet Explorer
Screen readers: NVDA (latest version), JAWS (latest version)
Mac, Apple iOS, Apple iPadOS: VoiceOver
Android OS TalkBack (latest version)
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Enquiring Minds, LLC,and/or Genentech. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
For CME questions please contact: 800-421-3756
Medical Education Resources and Enquiring Minds, LLC maintain high standards for the protection of privacy over the Internet. The purpose of this statement is to explain what information we obtain, how it is used, and how visitors can restrict its use or disclosure.